H. Yan

Inhibitory effects of GT0918 on acute lung injury and the molecular mechanisms of anti-inflammatory response

Qianxiang Zhou, Y. Tong, Liandong Ma, 2022, bioRxiv.

A Dendritic Cell Vaccine Combined With Radiotherapy Activates the Specific Immune Response in Patients With Esophageal Cancer

Chengshi Wang, J. Pu, Hanxu Yu, 2017, Journal of immunotherapy.

Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer

Huiping Li, Qianxiang Zhou, Qiaoxia Zhou, 2021, Breast Cancer Research and Treatment.

Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer.

J. Hou, Qianxiang Zhou, S. Ren, 2020, European journal of cancer.

Suppression of Androgen Receptor (AR)-ACE2/TMPRSS2 Axis by AR Antagonists May Be Therapeutically Beneficial for Male COVID-19 Patients

Yifeng Zhou, Jianfei Yang, Qianxiang Zhou, 2020 .

Phase I study of the antineovascularization drug CM101.

C. Hellerqvist, D. Johnson, H. Sundell, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response

A. Chinnaiyan, Xuhong Cao, J. Qin, 2023, Proceedings of the National Academy of Sciences of the United States of America.